INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined grapes. Clear

An expert overview of the literature, useful as background reading.

2 studies

2012 / Editorial / commentary on a randomized phase II trial

A commentary reports that 60 g/day of strawberry powder reduced the histologic grade of dysplastic lesions in an esophageal cancer prevention trial.

This commentary discusses a randomized noncomparative phase II trial in China testing two doses of strawberry powder (60 g/d or 30 g/d for six months) to prevent esophageal cancer. The 60 g/d dose reduced the histologic grade of dysplastic lesions and reduced localized biomarkers, whereas the 30 g/d dose was not effective. The author notes that fundamental questions remain regarding formulation, active components, and mechanisms of action.

Suh N, Pezzuto JM Cancer Prev Res (Phila), 2012. PMID 22219164

2011 / Narrative review

A review summarizes human pharmacokinetic and pharmacodynamic data for resveratrol, noting a lack of clinical evidence and conflicting capsule versus food data.

This review examines nutrapharmacology and the therapeutic potential of resveratrol, a polyphenol found in grape skins and other plants, for targeting aging and obesity-related chronic diseases. It evaluates laboratory findings on inflammation and oxidative stress alongside published human pharmacokinetic and pharmacodynamic data. The authors note key obstacles to clinical use, including a lack of clinical evidence to date, a myriad of available doses and formulations, conflicting data on capsules versus food forms, and uncertain effects of long-term dosing.

Chachay VS, Kirkpatrick CM, Hickman IJ, et al. Br J Clin Pharmacol, 2011. PMID 21410504